Wednesday, April 22, 2026

LG CNS Teams Up with S-OIL for AI-Driven Smart Factory Revolution

LG CNS partners with S-OIL to implement AI technology for smart factories, enhancing safety and efficiency in refinery operations.

How U.S. Naval Protection in Hormuz is Impacting Global Oil Prices: A Deep Dive

International oil prices decline as U.S. commits to escort vessels through the Strait of Hormuz amid tensions with Iran.

Toss Securities Faces Second U.S. Stock Trading Outage in Two Weeks

Toss Securities faced another outage, hindering users from accessing stock listings and balances during U.S. market hours.

Dae Hyeon Moon

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

Latest Neonatal Resuscitation Guidelines: Key Insights for Healthcare Professionals

GE Healthcare Korea held a webinar on neonatal resuscitation guidelines to enhance perinatal care and improve treatment outcomes.

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

JLK’s Stroke AI Goes Subscription-Based as University Hospitals Drive Adoption

JLK's stroke AI solution enhances diagnosis and treatment at Chung-Ang University Hospital, improving patient care and revenue growth.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Unlocking Opportunities: Highlights from the 2026 J.P. Morgan Healthcare Conference in San Francisco

The 44th JP Morgan Healthcare Conference in San Francisco drew a large crowd of professionals in formal attire early in the morning.

Global Pharma Giants Join Samsung Biologics in Major Climate Pledge to Cut Supply-Chain Emissions by 2030

Samsung Biologics leads a global initiative to reduce carbon emissions in healthcare, aiming for sustainability and renewable energy by 2030.

Tylenol Stock Plunges: Trump’s Autism Warning Rattles $17B Market

Tylenol faces scrutiny over potential autism link during pregnancy, with mixed responses from the medical community and FDA caution.

CG MedTech’s Spine System Gets U.S. Debut in Texas Surgery

CG MedTech's INNOVERSE Spinal System gains FDA clearance and is successfully used in surgeries, marking a milestone for Korean medical devices.

Top News

- Our Sponsors Ad -

Follow us